BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim KS, Iwanami S, Oda T, Fujita Y, Kuba K, Miyazaki T, Ejima K, Iwami S. Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection. Life Sci Alliance 2021;4:e202101049. [PMID: 34344719 DOI: 10.26508/lsa.202101049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tatematsu D, Akao M, Park H, Iwami S, Ejima K, Iwanami S. Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors. J Theor Biol 2023;561:111403. [PMID: 36586664 DOI: 10.1016/j.jtbi.2022.111403] [Reference Citation Analysis]
2 Ejima K, Kim KS, Bento AI, Iwanami S, Fujita Y, Aihara K, Shibuya K, Iwami S. Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study. BMC Infect Dis 2022;22:656. [PMID: 35902832 DOI: 10.1186/s12879-022-07646-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hafez W, Saleh H, Al Baha Z, Tariq M, Hamdan S, Ahmed S. Antiviral Used among Non-Severe COVID-19 Cases in Relation to Time till Viral Clearance: A Retrospective Cohort Study. Antibiotics 2022;11:498. [DOI: 10.3390/antibiotics11040498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ferrari Gianlupi J, Mapder T, Sego TJ, Sluka JP, Quinney SK, Craig M, Stratford RE, Glazier JA. Multiscale Model of Antiviral Timing, Potency, and Heterogeneity Effects on an Epithelial Tissue Patch Infected by SARS-CoV-2. Viruses 2022;14:605. [DOI: 10.3390/v14030605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]